Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06570850
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand The main questions it aims to answer the following main questions
1 Which group has better clinical response at end of treatment
2 Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment
1 Which group has better clinical response at end of treatment
2 Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment
Detailed Description:
Participants will be randomized in a 11 ratio to receive a combination of intravenous colistin plus intravenous fosfomycin combination group or colistin alone monotherapy group to determine if monotherapy or combination therapy has a better outcome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None